InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by Brenner Randall B., Dirigeant. Director active across 1 companies, notably Paratek Pharmaceuticals, Inc.. Aggregated, 7 disclosures have been logged. Total volume traded: €35k. The latest transaction was disclosed on 15 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
067,500 shares0
Common Stock
SEC:0000904454-22-000264:0·
€17,5014,479 shares@ €3.9074100.0% of flow
Common Stock
SEC:0000904454-21-000844·
€17,5014,479 shares@ €3.907450.0% of flow
Common Stock
SEC:0000904454-21-000844:0·
021,250 shares0
Common Stock
SEC:0000904454-21-000624·
021,250 shares0
Common Stock
SEC:0000904454-21-000624:0·
028,636 shares0
Common Stock
SEC:0000904454-21-000516·
028,636 shares0
Common Stock
SEC:0000904454-21-000516:0·
7 of 7 declarations
About Brenner Randall B.
Randall B. Brenner is associated with Paratek Pharmaceuticals, Inc. Although his specific role is not detailed, he contributes to the leadership and strategy of the company. Brenner is involved in initiatives that support the company's objectives in the pharmaceutical sector.
